23/05/2026
trial::
PROgnostic Value of Precision Medicine in Patients With Myocardial Infarction and Non-obStructive Coronary artEries.
Study population
Patients with suspected MINOCA:
Acute MI by Fourth Universal Definition
Coronary angiography: no stenosis >50%
No obvious alternative diagnosis explaining presentation
Trial design
randomized trial, comparing:
1) Stratified treatment arm
Advanced diagnostic workup to identify the actual MINOCA mechanism, then therapy tailored to the cause.
included:
OCT: plaque rupture/erosion, SCAD
Acetylcholine provocation test: epicardial or microvascular spasm
Cardiac MRI: confirm MI; exclude myocarditis/Takotsubo
TEE: search for embolic source
2) Standard of care arm
Mainly angiography-based routine care, with CMR recommended, and empirical ACS-style treatment: antiplatelet/statin ± beta-blocker/ACE inhibitor as indicated.
Etiology found in stratified arm
Advanced workup identified the mechanism in 80% of cases. Most common causes were:
Frequency
Epicardial spasm 35.6%
Atherosclerotic plaque instability 22.2%
SCAD 13.3%
Coronary embolism 4.4%
Microvascular spasm 4.4%
Undefined 20%
Initial suspected diagnosis was reclassified in 75.5% of stratified-arm cases.
according to cause
The key message is: treat the mechanism, not just the angiogram.
Mechanism Targeted treatment approach
Plaque instability DAPT ± PCI, statin
SCAD Antiplatelet ± PCI, beta-blocker
Epicardial/microvascular spasm Calcium channel blocker
Coronary embolism Anticoagulation
Undefined Standard ACS therapy
endpoint
Change in angina status at 12 months, measured by Seattle Angina Questionnaire Summary Score — SAQSS.
:
Outcome Stratified treatment Standard care p value
SAQ Summary Score improvement 12.3 ± 5.2 2.9 ± 9.5